Clinical Trial Update: Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

View source ↗

Summary

Clinical trial update on tumor-informed ctDNA testing for minimal residual disease after treatment in head and neck squamous cell carcinoma and cutaneous squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Squamous Cell Carcinoma of Head and Neck, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | Status: RECRUITING